Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Paul Engstrom

Email
Center AffiliationsCancer Prevention and Control

Publications (136) (print view)

paginate
Yao JC, Garg A, Chen D, Capdevila J, Engstrom P, Pommier R, Van Cutsem E, Singh S, Fazio N, He W, Riester M, Patel P, Voi M, Morrissey M, Pavel ME, Kulke MH. Genomic profiling of NETs: a comprehensive analysis of the RADIANT trials. Endocrine-related cancer. 2019 Apr;26(4):391-403.
Benson AB, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF, Garrido-Laguna I, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Miller ED, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wuthrick E, Gregory KM, Freedman-Cass DA. NCCN Guidelines Insights: Colon Cancer, Version 2.2018. J Natl Compr Canc Netw. 2018 Apr;16(4):359-69.
Benson A, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wuthrick E, Gregory KM, Freedman-Cass DA. Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018 Jul;16(7):852-71.
Benson A, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wuthrick E, Gregory KM, Gurski L, Freedman-Cass DA. Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018 Jul;16(7):874-901.   PMCID: N/A
Lubner S, Feng Y, Mulcahy M, O'Dwyer P, Giang GY, Hinshaw JL, Deming D, Klein L, Teitelbaum U, Payne J, Engstrom P, Stella P, Meropol N, Benson A. E4206: AMG 706 and Octreotide in Patients with Low-Grade Neuroendocrine Tumors. The oncologist. 2018 Sep;23(9):1006-e104.   PMCID: PMC6192662
Shah MH, Goldner WS, Halfdanarson TR, Bergsland E, Berlin JD, Halperin D, Chan J, Kulke MH, Benson AB, Blaszkowsky LS, Eads J, Engstrom PF, Fanta P, Giordano T, He J, Heslin MJ, Kalemkerian GP, Kandeel F, Khan SA, Kidwai WZ, Kunz PL, Kuvshinoff BW, Lieu C, Pillarisetty VG, Saltz L, Sosa JA, Strosberg JR, Sussman CA, Trikalinos NA, Uboha NA, Whisenant J, Wong T, Yao JC, Burns JL, Ogba N, Zuccarino-Catania G. NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018. J Natl Compr Canc Netw. 2018 Jun;16(6):693-702.
Benson AB, Venook AP, Cederquist L, Chan E, Chen YJ, Cooper HS, Deming D, Engstrom PF, Enzinger PC, Fichera A, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wu CS, Gregory KM, Freedman-Cass D. Colon cancer, version 1.2017: Clinical practice guidelines in oncology. JNCCN Journal of the National Comprehensive Cancer Network. 2017 Mar;15(3):370-98.
Newman LA, Stark A, Chitale D, Pepe M, Longton G, Worsham MJ, Nathanson D, Miller P, Bensenhaver JM, Proctor E, Swain M, Patriotis C, Engstrom PF. Association Between Benign Breast Disease in African American and White American Women and Subsequent Triple-Negative Breast Cancer. Jama Oncology. 2017 Aug;3(8):1102-6.
Newman LA, Stark A, Chitale D, Pepe M, Longton G, Worsham MJ, Nathanson SD, Miller P, Bensenhaver JM, Proctor E, Swain M, Patriotis C, Engstrom PF. Association Between Benign Breast Disease in African American and White American Women and Subsequent Triple-Negative Breast Cancer. JAMA Oncol. 2017 Aug;3(8):1102-6.   PMCID: PMC5796807
Vijayvergia N, Boland PM, Handorf E, Gustafson KS, Gong Y, Cooper HS, Sheriff F, Astsaturov I, Cohen SJ, Engstrom PF. Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot Study. Br J Cancer. 2016 Aug 23;115(5):564-70.   PMCID: PMC4997552
Benson AB, Venook AP, Bekaii-Saab T, Chan E, Chen YJ, Cooper HS, Engstrom PF, Enzinger PC, Fenton MJ, Fuchs CS, Grem JL, Grothey A, Hochster HS, Hunt S, Kamel A, Kirilcuk N, Leong LA, Lin E, Messersmith WA, Mulcahy MF, Murphy JD, Nurkin S, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Gregory KM, Freedman-Cass D. Rectal Cancer, Version 2.2015. J Natl Compr Canc Netw. 2015 Jun;13(6):719-28.
Benson AB, Venook AP, Bekaii-Saab T, Chan E, Chen YJ, Cooper HS, Engstrom PF, Enzinger PC, Fenton MJ, Fuchs CS, Grem JL, Grothey A, Hochster HS, Hunt S, Kamel A, Kirilcuk N, Leong LA, Lin E, Messersmith WA, Mulcahy MF, Murphy JD, Nurkin S, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Gregory KM, Freedman-Cass D. Rectal cancer, version 2.2015: Featured updates to the NCCN guidelines. JNCCN Journal of the National Comprehensive Cancer Network. 2015 Jan;13(6):719-28.
Kulke MH, Shah MH, Benson AB, Bergsland E, Berlin JD, Blaszkowsky LS, Emerson L, Engstrom PF, Fanta P, Giordano T, Goldner WS, Halfdanarson TR, Heslin MJ, Kandeel F, Kunz PL, Kuvshinoff BV, Lieu C, Moley JF, Munene G, Pillarisetty VG, Saltz L, Sosa JA, Strosberg JR, Vauthey JN, Wolfgang C, Yao JC, Burns J, Freedman-Cass D. Neuroendocrine Tumors, Version 1.2015. Journal of the National Comprehensive Cancer Network. 2015 Jan;13(1):78-108.
Marks JR, Anderson KS, Engstrom P, Godwin AK, Esserman LJ, Longton G, Iversen ES, Mathew A, Patriotis C, Pepe MS. Construction and Analysis of the NCI-EDRN Breast Cancer Reference Set for Circulating Markers of Disease. Cancer Epidemiol Biomarkers Prev. 2015 Feb;24(2):435-41.   PMCID: Pmc4323938
Benson AB, Venook AP, Bekaii-Saab T, Chan E, Chen YJ, Cooper HS, Engstrom PF, Enzinger PC, Fenton MJ, Fuchs CS, Grem JL, Hunt S, Kamel A, Leong LA, Lin E, Messersmith W, Mulcahy MF, Murphy JD, Nurkin S, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Gregory KM, Freedman-Cass DA. Colon Cancer, Version 3.2014. Journal of the National Comprehensive Cancer Network. 2014 Jul;12(7):1028-59.   PMCID: No NIH funds
Denlinger CS, Meropol NJ, Li T, Lewis NL, Engstrom PF, Weiner LM, Cheng JD, Alpaugh RK, Cooper H, Wright JJ, Cohen SJ. A Phase II Trial of the Proteasome Inhibitor Bortezomib in Patients With Advanced Biliary Tract Cancers. Clinical Colorectal Cancer. 2014 Jun;13(2):81-6.   PMCID: Pmc4189831
Perkins J, Boland P, Cohen SJ, Olszanski AJ, Zhou Y, Engstrom P, Astsaturov I. Successful Imatinib Therapy for Neuroendocrine Carcinoma With Activating KIT Mutation: A Case Study. J Natl Compr Canc Netw. 2014 Jun;12(6):847-52.   PMCID: PMC4112647
Benson AB, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, Engstrom PF, Enzinger PC, Fakih MG, Fenton MJ, Fuchs CS, Grem JL, Hunt S, Kamel A, Leong LA, Lin E, May KS, Mulcahy MF, Murphy K, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Small W, Sofocleous CT, Venook AP, Willett CG, Gregory KM, Freedman-Cass DA. Localized Colon Cancer, Version 3.2013 Featured Updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network. 2013 May;11(5):519-28.   PMCID: No NIH funds
Engstrom PF. Physician burnout. J Natl Compr Canc Netw. 2013 Apr;11(4):502-4.   PMCID: Editorial
Gordiev M, Engstrom PF, Khasanov R, Moroshek A, Sitdikov R, Dgavoronkov V, Schnoll RA. Genetic analysis of polymorphisms in dopamine receptor and transporter genes for association with smoking among cancer patients. European Addiction Research. 2013 Feb;19(2):105-11.   PMCID: PMC 3649069
Khrizman P, Niland JC, ter Veer A, Milne D, Dunn KB, Carson WE, Engstrom PF, Shibata S, Skibber JM, Weiser MR, Schrag D, Benson AB. Postoperative Adjuvant Chemotherapy Use in Patients With Stage II/III Rectal Cancer Treated With Neoadjuvant Therapy: A National Comprehensive Cancer Network Analysis. Journal of Clinical Oncology. 2013 Jan;31(1):30-8.
Benson A, Arnoletti JP, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Engstrom PF, Enzinger PC, Fakih MG, Fleshman JW, Fuchs CS, Grem JL, Leong LA, Lin E, May KS, Mulcahy MF, Murphy K, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Small W, Sofocleous CT, Venook AP, Willett C, Freedman-Cass DA. Anal Carcinoma, Version 2.2012 Featured Updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network. 2012 Apr;10(4):449-54.   PMCID: not NIH funded
Cauchi C, Somaiah N, Engstrom PF, Litwin S, Lopez M, Lee J, Davey M, Bove B, von Mehren M. Evaluation of nilotinib in advanced GIST previously treated with imatinib and sunitinib. Cancer Chemotherapy and Pharmacology. 2012 Apr;69(4):977-82.   PMCID: PMC3313017
Kulke MH, Benson AB, Bergsland E, Berlin JD, Blaszkowsky LS, Choti MA, Clark OH, Doherty GM, Eason J, Emerson L, Engstrom PF, Goldner WS, Heslin MJ, Kandeel F, Kunz PL, Kuvshinoff BW, Moley JF, Pillarisetty VG, Saltz L, Schteingart DE, Shah MH, Shibata S, Strosberg JR, Vauthey JN, White R, Yao JC, Freedman-Cass DA, Dwyer MA. Neuroendocrine Tumors Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2012 Jun;10(6):724-64.   PMCID: not NIH funded
Anderson KS, Sibani S, Wallstrom G, Qiu J, Mendoza EA, Raphael J, Hainsworth E, Montor WR, Wong J, Park JG, Lokko N, Logvinenko T, Ramachandran N, Godwin AK, Marks J, Engstrom P, LaBaer J. Protein Microarray Signature of Autoantibody Biomarkers for the Early Detection of Breast Cancer. Journal of Proteome Research. 2011 Jan;10(1):85-96.   PMCID: PMC3158028
Benson AB, Arnoletti JP, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Engstrom PF, Enzinger PC, Fleshman JW, Fuchs CS, Grem JL, Knol JA, Leong LA, Lin E, May KS, Mulcahy MF, Murphy K, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Small W, Sofocleous CT, Venook AP, Willett C. Colon cancer. J Natl Compr Canc Netw. 2011 Nov;9(11):1238-90.   PMCID: not NIH funded
Denlinger CS, Engstrom PF. Colorectal cancer survivorship: movement matters. Cancer prevention research (Philadelphia, Pa). 2011 Apr;4(4):502-11.   PMCID: PMC3110682
Gupta S, Engstrom PF, Cohen SJ. Emerging Therapies for Advanced Gastroenteropancreatic Neuroendocrine Tumors. Clinical Colorectal Cancer. 2011 Dec;10(4):298-309.   PMCID: NIHMS329029
O'Grady MA, Slater E, Sigurdson ER, Meropol NJ, Weinstein A, Lusch CJ, Sein E, Keeley P, Miller B, Engstrom PF, Cohen SJ. Assessing Compliance with National Comprehensive Cancer Network Guidelines for Elderly Patients with Stage III Colon Cancer: The Fox Chase Cancer Center Partners' Initiative. Clinical Colorectal Cancer. 2011 Jun;10(2):113-6.   PMCID: PMC3388796
Schnoll RA, Subramanian S, Martinez E, Engstrom PF. Correlates of continued tobacco use and intention to quit smoking among Russian cancer patients. International journal of behavioral medicine. 2011 Jan;18(4):325-32.   PMCID: PMC3107931
Chun YS, Milestone BN, Watson JC, Cohen SJ, Burtness B, Engstrom PF, Haluszka O, Tokar JL, Hall MJ, Denlinger CS, Astsaturov I, Hoffman JP. Defining Venous Involvement in Borderline Resectable Pancreatic Cancer. Annals of Surgical Oncology. 2010 Nov;17(11):2832-8.   PMCID: no NIH funding
Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, Shibata D, Skibber JM, Sofocleous C, Thomas J, Venook AP, Willett C, National Comprehensive Cancer N. NCCN Clinical Practice Guidelines in Oncology: rectal cancer. J Natl Compr Canc Netw. 2009 Sep;7(8):838-81.   PMCID: not NIH funded
Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, Shibata D, Skibber JM, Sofocleous C, Thomas J, Venook AP, Willett C, National Comprehensive Cancer N. NCCN Clinical Practice Guidelines in Oncology: colon cancer. J Natl Compr Canc Netw. 2009 Sep;7(8):778-831.   PMCID: not NIH funded
Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, Shibata D, Skibber JM, Sofocleous C, Thomas J, Venook AP, Willett C. Colon Cancer. Journal of the National Comprehensive Cancer Network. 2009 Sep;7(8):778-831.   PMCID: no NIH - Practice Guideline
Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, Shibata D, Skibber JM, Sofocleous C, Thomas J, Venook AP, Willett C. Rectal Cancer. Journal of the National Comprehensive Cancer Network. 2009 Sep;7(8):838-81.   PMCID: not NIH funded
Cohen SJ, Engstrom PF, Lewis NL, Langer CJ, McLaughlin S, Beard M, Weiner LM, Meropol NJ. Phase I study of capecitabine and oxaliplatin in combination with the proteasome inhibitor bortezomib in patients with advanced solid tumors. American Journal of Clinical Oncology-Cancer Clinical Trials. 2008 Feb;31(1):1-5.
Engstrom PF. Systemic therapy for advanced or metastatic colorectal cancer: national comprehensive cancer network guidelines for combining anti-vascular endothelial growth factor and anti-epidermal growth factor receptor monoclonal antibodies with chemotherapy. Pharmacotherapy. 2008 Nov;28(11 Pt 2):18S-22S.
Coudry RA, Meireles SI, Stoyanova R, Cooper HS, Carpino A, Wang XQ, Engstrom PF, Clapper ML. Successful application of microarray technology to microdissected formalin-fixed, paraffin-embedded tissue. Journal of Molecular Diagnostics. 2007 Feb;9(1):70-9.
Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Early DS, Fakih MG, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW, Rao S, Saltz L, Shibata D, Skibber JM, Venook AP. Colon cancer. J Natl Compr Canc Netw. 2007 Oct;5(9):884-925.
Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Early DS, Fakih MG, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW, Rao S, Saltz L, Shibata D, Skibber JM, Venook AP. Rectal cancer. J Natl Compr Canc Netw. 2007 Oct;5(9):940-81.
Wong Y-N, Change W-C, Clapper M, Engstrom PE. Chemoprevention of colorectal cancer. In: Saltz LB, editor. Colorectal cancer : evidence-based chemotherapy strategies. Totowa, N.J.: Humana Press; 2007. p. 33-49.
Wong YN, Chang WC, Clapper M, Engstrom PF. Chemoprevention of colorectal cancer. In: Saltz LB, editor. Colorectal cancer : evidence-based chemotherapy strategies. Totowa, N.J.: Humana Press; 2007. p. 33-50.
Engstrom P, Clapper M. Prevention of tobacco-related cancers. In: Kufe DW, Bast RC, Hait WN, Hong WG, Pollock RE, Weichselbaum RR, Holland J, Frei E, editors. Cancer Medicine 7. Ontario, Canada: B.C. Dekker, Inc.; 2006. p. 354-62.
Engstrom PF. Progress in Chemoprevention: AACR Task Force Report. Clin Cancer Res. 2006 Jun 15;12(12):3645.
Engstrom PF, Langer CJ. The Balducci article reviewed. ONCOLOGY-NEW YORK. 2006 Feb;20(2):144-+.
Fang CY, Daly MB, Miller SM, Zerr T, Malick J, Engstrom P. Coping with ovarian cancer risk: The moderating effects of perceived control on coping and adjustment. British journal of health psychology. 2006 Nov;11(Pt 4):561-80.
Kelloff GJ, Lippman SM, Dannenberg AJ, Sigman CC, Pearce HL, Reid BJ, Szabo E, Jordan VC, Spitz MR, Mills GB, Papadimitrakopoulou VA, Lotan R, Aggarwal BB, Bresalier RS, Kim J, Arun B, Lu KH, Thomas ME, Rhodes HE, Brewer MA, Follen M, Shin DM, Parnes HL, Siegfried JM, Evans AA, Blot WJ, Chow WH, Blount PL, Maley CC, Wang KK, Lam S, Lee JJ, Dubinett SM, Engstrom PF, Meyskens FL, O'Shaughnessy J, Hawk ET, Levin B, Nelson WG, Hong WK. Progress in chemoprevention drug development: The promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer - A plan to move forward. CLINICAL CANCER RESEARCH. 2006 Jun;12(12):3661-97.
Schnoll RA, Engstrom PF, Subramanian S, Demidov L, Wielt DB. Smoking cessation counseling by Russian oncologists: opportunities for intervention in the Russian Federation. International journal of behavioral medicine. 2006 Jan;13(1):8-15.
Schnoll RA, Engstrom PF, Subramanian S, Demidov L, Wielt DB, Tighiouart M. Prevalence and correlates of tobacco use among Russian cancer patients: implications for the development of smoking cessation interventions at a cancer center in Russia. International journal of behavioral medicine. 2006 Jan;13(1):16-25.
Engstrom P. Update: NCCN colon cancer Clinical Practice Guidelines. J Natl Compr Canc Netw. 2005 Nov;3 Suppl 1:S25-8.
Engstrom PF, Benson AB, Chen YJ, Choti MA, Dilawari RA, Enke CA, Fakih MG, Fuchs C, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW, Rao S, Saif MW, Saltz L, Skibber JM, Venook AP, Yeatman TJ, National Comprehensive Cancer N. Anal canal cancer clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network. 2005 Jul;3(4):510-5.
Engstrom PF, Benson AB, Chen YJ, Choti MA, Dilawari RA, Enke CA, Fakih MG, Fuchs C, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW, Rao S, Saif MW, Saltz L, Skibber JM, Venook AP, Yeatman TJ, National Comprehensive Cancer N. Rectal cancer clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network. 2005 Jul;3(4):492-508.
Engstrom PF, Benson AB, Chen YJ, Choti MA, Dilawari RA, Enke CA, Fakih MG, Fuchs C, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW, Rao S, Saif MW, Saltz L, Skibber JM, Venook AP, Yeatman TJ, National Comprehensive Cancer N. Colon cancer clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network. 2005 Jul;3(4):468-91.
Konski A, Hoffman J, Sigurdson E, Haluszka O, Engstrom P, Cheng JD, Cohen SJ, Watson JC, Eisenberg D, McGarrity E, Freedman G, Meropol NJ. Can molecular imaging predict response to preoperative chemoradiation in patients with rectal cancer? A Fox Chase Cancer Center prospective experience. SEMINARS IN ONCOLOGY. 2005 Jan;32(6):S63-S67.
Schnoll RA, Wang H, Miller SM, Babb JS, Cornfeld MJ, Tofani SH, Hennigan-Peel T, Balshem A, Slater E, Ross E, Boyd CS, Engstrom PF. Change in Worksite Smoking Behavior Following Cancer Risk Feedback: A Pilot Study. American journal of health behavior. 2005 Jan;29(3):215-27.
Schnoll RA, Engstrom PF. Tobacco control in the physician's office: A matter of adequate training and resources. Journal of the National Cancer Institute. 2004 Apr;96(8):573-5.
Tsai YY, McGlynn KA, Hu Y, Cassidy AB, Arnold J, Engstrom PF, Buetow KH. Genetic susceptibility and dietary patterns in lung cancer (vol 41, pg 269, 2003). Lung Cancer. 2004 May;44(2):271.
Bruner DW, Moore D, Parlanti A, Dorgan J, Engstrom P. Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis. International journal of cancer. 2003 Dec 10;107(5):797-803.
Diefenbach MA, Hamrick N, Uzzo R, Pollack A, Horwitz E, Greenberg R, Engstrom PF. Clinical, demographic and psychosocial correlates of complementary and alternative medicine use by men diagnosed with localized prostate cancer. Journal of Urology. 2003 Jul;170(1):166-9.
Engstrom PF, Clapper ML, Schnoll RA. Prevention of tobacco-related cancer. In: Kufe DW, Pollock RE, Weichselbaum RR, Bast RC, Gansler TS, Holland JF, Frei E, American Cancer Society, editors. Cancer medicine 6. Hamilton, Ont. ; Lewiston, NY: BC Decker; 2003. p. 383-96.
Engstrom PF, Sigurdson E, Evans AA, Pingpank JF. Primary neoplams of the liver. In: Kufe DW, Pollock RE, editors. Cancer medicine. Hamilton, Ontario ; New York: B.C. Decker; 2003. p. 1542-53.
Fang CY, Miller SM, Malick J, Babb J, Engstrom PF, Daly MB. Psychosocial correlates of intention to undergo prophylactic oophorectomy among women with a family history of ovarian cancer. Prev Med. 2003 Nov;37(5):424-31.
Schnoll RA, Zhang B, Rue M, Krook JE, Spears WT, Marcus AC, Engstrom PF. Brief physician-initiated quit-smoking strategies for clinical oncology settings: a trial coordinated by the eastern cooperative oncology group. Journal of Clinical Oncology. 2003 Jan;21(2):355-65.
Uzzo RG, Watkins-Bruner D, Horwitz EM, Konski A, Pollack A, Engstrom PF, Kolenko V. Prostate cancer prevention: strategies and realities. In: Mydlo JH, Godec CJ, editors. Prostate cancer : science and clinical practice. Amsterdam ; San Diego: Academic Press; 2003. p. 89-99.
Cornfeld MJ, Schnoll RA, Tofani SH, Babb JS, Miller SM, Henigan-Peel T, Balshem A, Slater E, Ross E, Siemers S, Montgomery S, Malstrom M, Hunt P, Boyd S, Engstrom PF. Implementation of a comprehensive cancer control program at the worksite: year one summary report. J Occup Environ Med. 2002 May;44(5):398-406.
Diefenbach MA, Dorsey J, Uzzo RG, Hanks GE, Greenberg RE, Horwitz E, Newton F, Engstrom PF. Decision-making strategies for patients with localized prostate cancer. Semin Urol Oncol. 2002 Feb;20(1):55-62.
Lewis NL, Scher R, Gallo JM, Engstrom PF, Szarka CE, Litwin S, Adams AL, Kilpatrick D, Brady D, Weiner LM, Meropol NJ. Phase I and pharmacokinetic study of irinotecan in combination with raltitrexed. Cancer Chemotherapy and Pharmacology. 2002 Oct;50(4):257-65.
Cornfeld MJ, Jadwin A, O'Grady P, Babb J, Engstrom PF. Feasibility of assessing quality in medical oncology practices. Cancer Pract. 2001 Sep;9(5):231-5.
Jadwin A, O'Grady P, Babb J, Engstrom PF. Feasibility of assessing quality in medical oncology practices. Cancer Practice. 2001 Jan;9(5):231-5.
Miller SM, Diefenbach MA, Kruus LK, Watkins-Bruner D, Hanks GE, Engstrom PF. Psychological and screening profiles of first-degree relatives of prostate cancer patients. J Behav Med. 2001 Jun;24(3):247-58.
Szarka CE, Yao KS, Pfeiffer GR, Balshem AM, Litwin S, Frucht H, Goosenberg EB, Engstrom PF, Clapper ML, O'Dwyer PJ. Chronic dosing of oltipraz in people at increased risk for colorectal cancer. Cancer Detect Prev. 2001 Jan;25(4):352-61.
Engstrom PF, Benson A, Choti MA, Cohen AM, Doroshow JH, Fuchs C, Kiel K, Martin EW, McGinn C, Petrelli NJ, Posey JA, Skibber JM, Venook A, Yeatman TJ. NCCN Practice Guidelines for colorectal cancer. Oncology-New York. 2000 Nov;14(11A):203-12.
Engstrom PF, Clapper M, Schnoll RA, Orleans CT. Prevention of tobacco-related cancers. In: Bast RC, Kufe DW, Pollock RE, Weichselbaum RR, Holland JF, Frei E, Gansler TS, American Cancer Society, editors. Cancer medicine. Hamilton, Ontario ; New York: B.C. Decker; 2000. p. 314-27.
Engstrom PF, Sigurdson E, Evans AA. Cancer medicine. In: Bast RC, Kufe DW, Holland JF, editors. Primary neoplasms of the liver. Hamilton, Ontario ; New York: B.C. Decker; 2000. p. 1391-401.
Higman SA, McKay FJ, Engstrom PF, O'Grady MA, Young RC. Fox Chase Network: Fox Chase Cancer Center's community hospital affiliation program. The oncologist. 2000 Jan;5(4):329-35.
Simunovic M, To T, Baxter N, Balshem A, Ross E, Cohen Z, McLeod R, Engstrom P, Sigurdson E. Hospital procedure volume and teaching status do not influence treatment and outcome measures of rectal cancer surgery in a large general population. J Gastrointest Surg. 2000 May;4(3):324-30.
Bruner DW, Baffoe-Bonnie A, Miller S, Diefenbach M, Tricoli JV, Daly M, Pinover W, Grumet SC, Stofey J, Ross E, Raysor S, Balshem A, Malick J, Engstrom P, Hanks GE, Mirchandani I. Prostate cancer risk assessment program. A model for the early detection of prostate cancer. Oncology (Huntingt). 1999 Mar;13(3):325-34; discussion 337-9, 343-4 pas.
Engstrom PF. A new era for cancer prevention and control research. Cancer Epidemiology Biomarkers & Prevention. 1999 Nov;8(11):955-6.
Garay CA, Engstrom PF. Chemoprevention of colorectal cancer: Dietary and pharmacologic approaches. Oncology-New York. 1999 Jan;13(1):89-97.
Liu SC, Hu Y, Sauter ER, Clapper ML, Chen SY, Lanfranchi HE, Engstrom PF, Klein-Szanto AJ. Image analysis of p53 and cyclin D1 expression in premalignant lesions of the oral mucosa. Analytical and Quantitative Cytology and Histology. 1999 Apr;21(2):166-73.
Miller SM, Fang CY, Manne SL, Engstrom PF, Daly MB. Decision making about prophylactic oophorectomy among at-risk women: Psychological influences and implications. Gynecologic Oncology. 1999 Dec;75(3):406-12.
Sauter ER, Ehya H, Babb J, Diamandis E, Daly M, Klein-Szanto A, Sigurdson E, Hoffman J, Malick J, Engstrom PF. Biological markers of risk in nipple aspirate fluid are associated with residual cancer and tumour size. Br J Cancer. 1999 Dec;81(7):1222-7.
Liu SC, Sauter ER, Clapper ML, Feldman RS, Levin L, Chen SY, Yen TJ, Ross E, Engstrom PF, Klein-Szanto AJ. Markers of cell proliferation in normal epithelia and dysplastic leukoplakias of the oral cavity. Cancer Epidemiol Biomarkers Prev. 1998 Jul;7(7):597-603.
Sauter ER, Babb J, Daly M, Engstrom PF, Ehya H, Malick J, Diamandis E. Prostate-specific antigen production in the female breast: Association with progesterone. Cancer Epidemiology Biomarkers & Prevention. 1998 Apr;7(4):315-20.
Shoda Y, Mischel W, Miller SM, Diefenbach M, Daly MB, Engstrom PF. Psychological interventions and genetic testing: Facilitating informed decisions about BRCA1/2 cancer susceptibility. Journal of Clinical Psychology in Medical Settings. 1998 Mar;5(1):3-17.
Witte RS, Ryan LM, Schutt AJ, Carbone PP, Engstrom PF. PALA versus streptozotocin, doxorubicin, and MeCCNU in the treatment of patients with advanced pancreatic carcinoma. Investigational New Drugs. 1998 Jan;16(4):315-8.
Clapper ML, Szarka CE, Pfeiffer GR, Graham TA, Balshem AM, Litwin S, Goosenberg EB, Frucht H, Engstrom PF. Preclinical and clinical evaluation of broccoli supplements as inducers of glutathione S-transferase activity. Clinical Cancer Research. 1997 Jan;3(1):25-30.
Lattanzi JP, Coia LR, Scher RM, Engstrom PF, Hoffman JP, Eisenberg BF, Sigursdson ER, Epstein BE, Weiner LM. A prospective phase I/II study of intra-arterial chemotherapy and escalating doses of radiation therapy for surgically unresectable carcinoma confined to the liver. Gi Cancer. 1997 Jan;2(2):111-7.
Sauter ER, Ross E, Daly M, Klein-Szanto A, Engstrom PF, Sorling A, Malick J, Ehya H. Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk. Br J Cancer. 1997 Jan;76(4):494-501.
Benincasa TA, King ES, Rimer BK, Bloom HS, Balshem A, James J, Engstrom PF. Results of an office-based training program in clinical breast examination for primary care physicians. Journal of Cancer Education. 1996 Jan;11(1):25-31.
Love RR, Engstrom PF. Cancer prevention and control investigators: The need for high quality training programs. Cancer Epidemiology Biomarkers & Prevention. 1996 Feb;5(2):141-2.
Odwyer PJ, Szarka CE, Yao KS, Halbherr TC, Pfeiffer GR, Green F, Gallo JM, Brennan J, Frucht H, Goosenberg EB, Hamilton TC, Litwin S, Balshem AM, Engstrom PF, Clapper ML. Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz. Journal of Clinical Investigation. 1996 Sep;98(5):1210-7.
Sauter ER, Daly M, Linahan K, Ehya H, Engstrom PF, Bonney G, Ross EA, Yu H, Diamandis E. Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1996 Dec;5(12):967-70.
Algan O, Coia LR, Keller SM, Engstrom PF, Weiner LM, Schultheiss TE, Hanks GE. Management of Adenocarcinoma of the Esophagus with Chemoradiation Alone or Chemoradiation Followed by Esophagectomy - Results of Sequential Nonrandomized Phase-Ii Studies. International Journal of Radiation Oncology Biology Physics. 1995 Jun 15;32(3):753-61.
Cohen AM, Kane MJ, Engstrom PF, Marks JH, Marks GJ, Haller DG, Schneider CJ, Laucius JF, Mastrangelo MJ. Dukes C2 Colon-Cancer - What Is Appropriate Follow-Up. Seminars in Oncology. 1995 Jun;22(3):R19-&.
Langer CJ, Leighton JC, Comis RL, Odwyer PJ, McAleer CA, Bonjo CA, Engstrom PF, Litwin S, Johnson S, Ozols RF. Paclitaxel by 24- or 1-Hour Infusion in Combination with Carboplatin in Advanced Nonsmall Cell Lung-Cancer - the Fox Chase Cancer Center Experience. Seminars in Oncology. 1995 Aug;22(4):18-29.
Langer CJ, Leighton JC, Comis RL, Odwyer PJ, McAleer CA, Bonjo CA, Engstrom PF, Litwin S, Ozols RF. Paclitaxel and Carboplatin in Combination in the Treatment of Advanced Non-Small-Cell Lung-Cancer - a Phase-Ii Toxicity, Response, and Survival Analysis. Journal of Clinical Oncology. 1995 Aug;13(8):1860-70.
Martenson JA, Lipsitz SR, Lefkopoulou M, Engstrom PF, Dayal YY, Cobau CD, Oken MM, Haller DG. Results of Combined-Modality Therapy for Patients with Anal Cancer (E7283) - an Eastern-Cooperative-Oncology-Group-Study. Cancer. 1995 Nov 15;76(10):1731-6.
Scher RM, Kosierowski R, Lusch C, Alexander R, Fox S, Redei I, Green F, Raskay B, Amfoh K, Engstrom PF, Odwyer PJ. Phase II trial of topotecan in advanced or metastatic adenocarcinoma of the pancreas. Investigational New Drugs. 1995 Jan;13(4):347-54.
Szarka CE, Pfeiffer GR, Hum ST, Everley LC, Balshem AM, Moore DF, Litwin S, Goosenberg EB, Frucht H, Engstrom PF, Clapper ML. Glutathione-S-Transferase Activity and Glutathione-S- Transferase Mu-Expression in Subjects with Risk for Colorectal- Cancer. Cancer Research. 1995 Jul;55(13):2789-93.
Clapper ML, Everley LC, Strobel LA, Townsend AJ, Engstrom PF. Coordinate Induction of Glutathione S-Transferase-Alpha, S- Transferase-Mu, and S-Transferase-Pi Expression in Murine Liver after a Single Administration of Oltipraz. Molecular Pharmacology. 1994 Mar;45(3):469-74.
Engstrom PF. Cancer Prevention and Control Priorities for the Year-2000 - a Commentary. Cancer. 1994 Aug 15;74(4):1433-7.
King ES, Rimer BK, Seay J, Balshem A, Engstrom PF. Promoting Mammography Use through Progressive Interventions - Is It Effective. American journal of public health. 1994 Jan;84(1):104-6.
Lerman C, Rimer BK, Daly M, Lustbader E, Sands C, Balshem A, Masny A, Engstrom P. Recruiting High-Risk Women into a Breast-Cancer Health Promotion Trial. Cancer Epidemiology Biomarkers & Prevention. 1994 Apr;3(3):271-6.
Szarka CE, Grana G, Engstrom P. Chemoprevention of Cancer. Current Problems in Cancer. 1994 Jan;18(1):1-78.
Taylor PR, Li B, Dawsey SM, Li JY, Yang CS, Guo WD, Blot WJ, Weng W, Liu BQ, Zheng SF, Yang Q, Yu Y, Sun Y, Li GY, Liu SF, Zhou XN, Wu YP, Wang Z, Lu SX, Zhang YH, Yang K, Yang G, Chen Z, Wang ZY, Zheng DH, Lian GT, Tangrea JA, Ershow AG, Mark SD, Gail M, Stone BJ, Fraumeni JF, Greenwald P, Lewin K, Nieberg R, Weiner M, Weinstein W, Engstrom P, Correa P, Lagakos S. Prevention of Esophageal Cancer - the Nutrition Intervention Trials in Linxian, China. Cancer Research. 1994 Apr;54(7):S2029-S2031.
Daly MB, Balshem M, Sands C, James J, Workman S, Engstrom PF. Academic detailing: A model for in-office CME. Journal of Cancer Education. 1993 Jan;8(4):273-80.
Engstrom PF. Predictors of Future Breast-Cancer Risk. Cancer Epidemiology Biomarkers & Prevention. 1993 Jan;2(1):1-2.
Hoffman JP, Weese JL, Solin LJ, Agarwal P, Engstrom P, Scher R, Paul AR, Litwin S, Watts P, Eisenberg BL, Sener SF, Bouwman DL, Aranha GV. A single institutional experience with preoperative chemoradiotherapy for stage I-III pancreatic adenocarcinoma. American Surgeon. 1993 Jan;59(11):772-81.
Lerman C, Daly M, Sands C, Balshem A, Lustbader E, Heggan T, Goldstein L, James J, Engstrom P. Mammography Adherence and Psychological Distress among Women at Risk for Breast-Cancer. Journal of the National Cancer Institute. 1993 Jul 07;85(13):1074-80.
Lerman C, Orleans CT, Engstrom PF. Biological Markers in Smoking Cessation Treatment. Seminars in Oncology. 1993 Aug;20(4):359-67.
Myers RE, Bralow SP, Goldstein R, Jacobs M, Wolf TA, Engstrom PF. Surveillance for Colorectal Neoplasia - Is Patient Adherence Following Treatment a Problem. Cancer Detection and Prevention. 1993 Jan;17(6):609-17.
Trock B, Rimer BK, King E, Balshem A, Cristinzio CS, Engstrom PF. Impact of an Hmo-Based Intervention to Increase Mammography Utilization. Cancer Epidemiology Biomarkers & Prevention. 1993 Mar;2(2):151-6.
Trock B, Rimer BK, King E, Balshem A, Suzanne Cristinzio C, Engstrom PF. Impact of an HMO-based intervention to increase mammography utilization. Cancer Epidemiology Biomarkers and Prevention. 1993 Jan;2(2):151-6.
Yeung RS, Weese JL, Hoffman JP, Solin LJ, Paul AR, Engstrom PF, Litwin S, Kowalyshyn MJ, Eisenberg BL. Neoadjuvant Chemoradiation in Pancreatic and Duodenal Carcinoma - a Phase-Ii Study. Cancer. 1993 Oct;72(7):2124-33.
Yeung RS, Weese JL, Hoffman JP, Solin LJ, Paul AR, Engstrom PF, Litwin S, Kowalyshyn MJ, Eisenberg BL. Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma: A Phase II study. Cancer. 1993 Jan;72(7):2124-33.
Daly M, Seay J, Balshem A, Lerman C, Engstrom P. Feasibility of a Telephone Survey to Recruit Health Maintenance Organization Members into a Tamoxifen Chemoprevention Trial. Cancer Epidemiology Biomarkers & Prevention. 1992 Jul;1(5):413-6.
Lerman C, Hanjani P, Caputo C, Miller S, Delmoor E, Nolte S, Engstrom P. Telephone Counseling Improves Adherence to Colposcopy among Lower-Income Minority Women. Journal of Clinical Oncology. 1992 Feb;10(2):330-3.
Lerman C, Ross E, Boyce A, Gorchov PM, McLaughlin R, Rimer B, Engstrom P. The Impact of Mailing Psychoeducational Materials to Women with Abnormal Mammograms. American journal of public health. 1992 May;82(5):729-30.
Rimer BK, Resch N, King E, Ross E, Lerman C, Boyce A, Kessler H, Engstrom PF. Multistrategy Health-Education Program to Increase Mammography Use among Women Ages 65 and Older. Public Health Reports. 1992 Jul;107(4):369-80.
Rosvold E, Schilder R, Walczak J, Difino SM, Flynn PJ, Banerjee TK, Heim WJ, Engstrom PF, Ozols RF, Odwyer PJ. Phase-Ii Trial of Pala in Combination with 5-Fluorouracil in Advanced Pancreatic-Cancer. Cancer Chemotherapy and Pharmacology. 1992 Feb;29(4):305-8.
Coia LR, Engstrom PF, Paul AR, Stafford PM, Hanks GE. Long-Term Results of Infusional 5-Fu, Mitomycin-C, and Radiation as Primary Management of Esophageal-Carcinoma. International Journal of Radiation Oncology Biology Physics. 1991 Jan;20(1):29-36.
Daly M, Lerman C, Sands C, Boyce A, Engstrom P. Impact of Coping Style on Risk Perception and Health Behavior in Women Genetically Predisposed to Breast-Cancer. American journal of human genetics. 1991 Oct;49(4):311.
Engstrom PF. Specific Compliance Issues in an Antiestrogen Trial of Women at Risk for Breast-Cancer. Preventive Medicine. 1991 Jan;20(1):125-31.
Engstrom PF, Ryan LM, Falkson G, Haller DG. Phase-Ii Study of Aminothiadiazole in Advanced Squamous-Cell Carcinoma of the Esophagus. American Journal of Clinical Oncology-Cancer Clinical Trials. 1991 Feb;14(1):33-5.
Kessler HB, Rimer BK, Devine PJ, Gatenby RA, Engstrom PF. Corporate-Sponsored Breast-Cancer Screening at the Work Site - Results of a Statewide Program. Radiology. 1991 Apr;179(1):107-10.
Lerman C, Daly M, Sands C, Ross E, Buetow K, Engstrom P. Risk Perceptions and Practices among Women with a Genetic Predisposition to Breast-Cancer. American journal of human genetics. 1991 Oct;49(4):314.
Lerman C, Rimer BK, Engstrom PF. Cancer Risk Notification - Psychosocial and Ethical Implications. Journal of Clinical Oncology. 1991 Jul;9(7):1275-82.
Lerman C, Trock B, Rimer BK, Boyce A, Jepson C, Engstrom PF. Psychological and Behavioral-Implications of Abnormal Mammograms. Annals of internal medicine. 1991 Apr 15;114(8):657-61.
Odwyer PJ, Lacreta F, Engstrom PF, Peter R, Tartaglia L, Cole D, Litwin S, Devito J, Poplack D, Delap RJ, Comis RL. Phase-I Pharmacokinetic Reevaluation of Thiotepa. Cancer Research. 1991 Jun 15;51(12):3171-6.
Engstrom PF, Levin B, Moertel CG, Schutt A. A Phase-Ii Trial of Tamoxifen in Hepatocellular-Carcinoma. Cancer. 1990 Jun 15;65(12):2641-3.
King ES, Rimer BK, Trock B, Balshem A, Engstrom P. How Valid Are Mammography Self-Reports. American journal of public health. 1990 Nov;80(11):1386-8.
Lerman C, Rimer B, Blumberg B, Cristinzio S, Engstrom PF, Macelwee N, Oconnor K, Seay J. Effects of Coping Style and Relaxation on Cancer-Chemotherapy Side-Effects and Emotional Responses. Cancer nursing. 1990 Oct;13(5):308-15.
Lerman C, Rimer B, Trock B, Balshem A, Engstrom PF. Factors Associated with Repeat Adherence to Breast-Cancer Screening. Preventive Medicine. 1990 May;19(3):279-90.
Myers RE, Trock BJ, Lerman C, Wolf T, Ross E, Engstrom PF. Adherence to Colorectal-Cancer Screening in an Hmo Population. Preventive Medicine. 1990 Sep;19(5):502-14.
Weese JL, Nussbaum ML, Paul AR, Engstrom PF, Solin LJ, Kowalyshyn MJ, Hoffman JP. Increased Resectability of Locally Advanced Pancreatic and Periampullary Carcinoma with Neoadjuvant Chemoradiotherapy. International Journal of Pancreatology. 1990 Aug;7(1-3):177-85.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

Paul Engstrom Sparkline Graph

Graph Interactions

Co-Authors:

Similar Investigators:


Keywords (MeSH):


Last updated on Friday, December 06, 2019